Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Increased transmissibility of the B.1.1.7 SARS-CoV-2 variant: Evidence from contact tracing data in Oslo, January to February 2021

Jonas Christoffer Lindstrøm, Solveig Engebretsen, Anja Bråthen Kristoffersen, Gunnar Øyvind Isaksson Rø, Alfonso Diz-Lois Palomares, Kenth Engø-Monsen, Elisabeth Henie Madslien, Frode Forland, Karin Maria Nygård, Frode Hagen, Gunnar Gantzel, Ottar Wiklund, Arnoldo Frigessi, Birgitte Freiesleben de Blasio
doi: https://doi.org/10.1101/2021.03.29.21254122
Jonas Christoffer Lindstrøm
1Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Solveig Engebretsen
2SAMBA, Norwegian Computing Center, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anja Bråthen Kristoffersen
1Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gunnar Øyvind Isaksson Rø
1Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfonso Diz-Lois Palomares
1Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenth Engø-Monsen
3Telenor Research, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth Henie Madslien
1Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frode Forland
1Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karin Maria Nygård
1Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frode Hagen
4Oslo Municipality Health Service, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gunnar Gantzel
4Oslo Municipality Health Service, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ottar Wiklund
4Oslo Municipality Health Service, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnoldo Frigessi
5Oslo Centre for Biostatistics and Epidemiology, Institute of Basic Medical Sciences, University of Oslo, Norway
6Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Birgitte Freiesleben de Blasio
1Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
5Oslo Centre for Biostatistics and Epidemiology, Institute of Basic Medical Sciences, University of Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Birgitte.Freiesleben.DeBlasio@fhi.no
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We use data from contact tracing in Oslo, Norway, to estimate the new SARS-CoV-2 B.1.1.7 lineage’s relative transmissibility. Within households, we find an increase in the secondary attack rate by 60% (20% 114%) compared to other variants. In general, we find a significant increase in the estimated reproduction number of 24% (95% CI 0% - 52%), or an absolute increase of 0.19 compared to other variants.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This project was funded by the Norwegian Research Council, project no. 312721 and 237718 and by Nordforsk project no. 105572.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The contact tracing data analysis was done following the data processor agreement between the Norwegian Institute of Public Health and Oslo Municipality, fulfilling Article 28 no. 3 of the EU regulation 2016/679 (GDPR) of 27 April 2016 and the Act on the processing of personal data of 15 June 2018 no. 38 and associated regulations (Privacy Regulations). The study concerns national health preparedness, and the role of the Norwegian Institute of Public Health is specified in the Health Preparedness Act and the Infection Control Act.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data is person sensitive and cannot be shared publically.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 30, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Increased transmissibility of the B.1.1.7 SARS-CoV-2 variant: Evidence from contact tracing data in Oslo, January to February 2021
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Increased transmissibility of the B.1.1.7 SARS-CoV-2 variant: Evidence from contact tracing data in Oslo, January to February 2021
Jonas Christoffer Lindstrøm, Solveig Engebretsen, Anja Bråthen Kristoffersen, Gunnar Øyvind Isaksson Rø, Alfonso Diz-Lois Palomares, Kenth Engø-Monsen, Elisabeth Henie Madslien, Frode Forland, Karin Maria Nygård, Frode Hagen, Gunnar Gantzel, Ottar Wiklund, Arnoldo Frigessi, Birgitte Freiesleben de Blasio
medRxiv 2021.03.29.21254122; doi: https://doi.org/10.1101/2021.03.29.21254122
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Increased transmissibility of the B.1.1.7 SARS-CoV-2 variant: Evidence from contact tracing data in Oslo, January to February 2021
Jonas Christoffer Lindstrøm, Solveig Engebretsen, Anja Bråthen Kristoffersen, Gunnar Øyvind Isaksson Rø, Alfonso Diz-Lois Palomares, Kenth Engø-Monsen, Elisabeth Henie Madslien, Frode Forland, Karin Maria Nygård, Frode Hagen, Gunnar Gantzel, Ottar Wiklund, Arnoldo Frigessi, Birgitte Freiesleben de Blasio
medRxiv 2021.03.29.21254122; doi: https://doi.org/10.1101/2021.03.29.21254122

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (413)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8551)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1744)
  • Geriatric Medicine (167)
  • Health Economics (371)
  • Health Informatics (1237)
  • Health Policy (619)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10283)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1671)
  • Nursing (97)
  • Nutrition (248)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (926)
  • Ophthalmology (263)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (247)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1764)
  • Public and Global Health (3832)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (319)
  • Respiratory Medicine (520)
  • Rheumatology (207)
  • Sexual and Reproductive Health (165)
  • Sports Medicine (157)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (74)